tiprankstipranks
Trending News
More News >
CME Group (CME)
NASDAQ:CME
Advertisement

CME Group (CME) AI Stock Analysis

Compare
1,925 Followers

Top Page

CME

CME Group

(NASDAQ:CME)

Select Model
Select Model
Select Model
Outperform 76 (OpenAI - 4o)
Rating:76Outperform
Price Target:
$301.00
▲(10.90% Upside)
CME Group's overall stock score reflects strong financial performance and a solid dividend yield, offset by mixed technical indicators and challenges highlighted in the earnings call. The company's strategic focus on growth areas like crypto and market data provides resilience against revenue declines and regulatory challenges.
Positive Factors
Strong Profitability
High profit margins indicate efficient operations and strong pricing power, providing a solid foundation for long-term financial stability and growth.
Record Market Data Revenue
Increasing market data revenue demonstrates growing demand for CME's data services, enhancing its revenue diversification and resilience.
Expansion into New Markets
Expanding into new regions like the Middle East opens up additional revenue streams and strengthens CME's global market presence.
Negative Factors
Revenue Decline
A decline in revenue suggests potential challenges in maintaining growth momentum, which could impact future financial performance.
Energy Volumes Decline
Decreased energy volumes may indicate reduced demand in a key segment, potentially affecting transaction fees and overall revenue.
Regulatory Challenges
Regulatory hurdles in launching new products could delay revenue diversification efforts and limit growth opportunities in emerging markets.

CME Group (CME) vs. SPDR S&P 500 ETF (SPY)

CME Group Business Overview & Revenue Model

Company DescriptionCME Group Inc. is a global leader in derivatives and futures exchanges, headquartered in Chicago, Illinois. The company operates four major exchanges: the Chicago Mercantile Exchange, the Chicago Board of Trade, the New York Mercantile Exchange, and the Commodity Exchange. CME Group provides a diverse range of products across various asset classes, including agricultural commodities, energy, equity indexes, interest rates, foreign exchange, and metals. Through its electronic trading platform and clearing services, CME Group facilitates price discovery and risk management for market participants worldwide.
How the Company Makes MoneyCME Group primarily generates revenue through transaction fees, which are charged to market participants for executing trades on its exchanges. The company earns income from various sources, including exchange fees, clearing fees, and market data services. Key revenue streams include trading volume across different asset classes, with higher volumes leading to increased transaction fees. Additionally, CME Group provides clearing services that offer risk management and settlement solutions, further contributing to its revenue. The company also benefits from partnerships and collaborations with financial institutions, proprietary trading firms, and other market participants, which help drive trading activity and enhance its service offerings. Overall, CME Group's business model is heavily reliant on the volume of trading activities and the associated fees collected from its users.

CME Group Key Performance Indicators (KPIs)

Any
Any
Total Contract Volume
Total Contract Volume
Measures the total number of contracts traded, indicating market activity levels and the company's ability to attract traders.
Chart InsightsCME Group's total contract volume is experiencing a robust upward trend, reaching new highs in 2025. This growth is fueled by record-breaking volumes in interest rates, agricultural commodities, and metals, as highlighted in the recent earnings call. The international business and retail trader expansion are key contributors, with a notable 18% increase in international volumes. Despite macroeconomic uncertainties and potential legal risks, CME's strong financial performance and strategic focus on expanding market participation underscore its resilience and growth potential.
Data provided by:Main Street Data

CME Group Earnings Call Summary

Earnings Call Date:Oct 22, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 18, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted strong performance in average daily volume, open interest, and market data revenue. However, the decline in overall revenue and energy volumes, along with regulatory challenges in prediction markets, presented areas of concern.
Q3-2025 Updates
Positive Updates
Second Highest Third Quarter Average Daily Volume
CME Group achieved an average daily volume of 25.3 million contracts, the second highest for a third quarter in its history.
Record Open Interest
Quarter-end open interest reached 126 million contracts, the highest for September in the last 5 years.
Crypto Complex Growth
Crypto complex traded a record 340,000 contracts per day, up over 225% from the previous year.
Market Data Revenue Record
Market data revenue exceeded $200 million for the first time, up 14% to $203 million.
Successful Launch of BrokerTec Chicago
BrokerTec Chicago launched with over $1 billion of notional traded since launch across all 7 tenors.
Adjusted Operating Income and Margin
CME Group reported adjusted operating income of $1.1 billion with a 68.4% operating margin.
Negative Updates
Revenue Decline
Quarterly revenue fell to $1.5 billion, a 3% decrease from the strong third quarter in 2024.
Energy Volumes Decline
Energy volumes were down this quarter after a long run of strong growth, attributed to stabilizing geopolitical risks.
Challenges in Prediction Markets
Uncertainty in regulatory approval for sports-related event contracts with FanDuel and concerns around some political event contracts.
Company Guidance
During the CME Group's third-quarter 2025 earnings call, the company provided guidance on several financial metrics. CME Group reported revenue of $1.5 billion, a decrease of 3% from the same quarter in 2024. The average rate per contract was $0.702, leading to clearing and transaction fees of $1.2 billion. Market data revenue reached a new high of $203 million, up 14%. The firm maintained strong cost discipline, with adjusted expenses at $487 million, or $405 million excluding license fees. Adjusted operating income was $1.1 billion, reflecting a 68.4% operating margin. The adjusted effective tax rate was 22.6%, and the adjusted net income was $978 million, resulting in adjusted diluted earnings per share of $2.68. Capital expenditures for the quarter were about $19 million, and cash on hand was approximately $2.6 billion. Additionally, CME Group paid dividends of $455 million in the third quarter. For the full year, the company expects total adjusted operating expenses, excluding license fees, to be about $1.625 billion, which is $10 million below their prior guidance and $25 million below their initial expectations for the year.

CME Group Financial Statement Overview

Summary
CME Group demonstrates strong profitability with high margins and steady revenue growth. The balance sheet is solid with low debt and strong return on equity. Cash flow is positive with room for improvement in cash generation efficiency.
Income Statement
85
Very Positive
CME Group demonstrates strong profitability with a high gross profit margin of 86.53% and a net profit margin of 58.28% in the TTM period. Revenue growth is steady at 2.54% TTM, indicating consistent performance. The EBIT and EBITDA margins are robust, reflecting efficient operations. Overall, the income statement shows a healthy financial position with consistent growth and strong profitability metrics.
Balance Sheet
80
Positive
The balance sheet is solid with a low debt-to-equity ratio of 0.12, indicating prudent financial leverage. Return on equity is strong at 13.72%, showcasing effective use of equity to generate profits. The equity ratio is healthy, suggesting a stable financial structure. Overall, the balance sheet reflects financial stability and effective management of liabilities.
Cash Flow
78
Positive
CME Group's cash flow statement shows positive trends with a 7.36% growth in free cash flow TTM. The operating cash flow to net income ratio is modest, suggesting room for improvement in cash generation relative to net income. The free cash flow to net income ratio is nearly 1, indicating efficient conversion of income to cash. Overall, the cash flow statement reflects solid cash management with potential for further optimization.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.40B6.13B5.58B5.02B4.69B4.88B
Gross Profit5.51B5.28B4.75B4.27B3.85B4.03B
EBITDA5.35B5.04B4.67B4.02B3.93B3.35B
Net Income3.75B3.53B3.23B2.69B2.64B2.11B
Balance Sheet
Total Assets187.14B137.45B129.71B174.18B196.78B124.66B
Cash, Cash Equivalents and Short-Term Investments2.58B3.01B3.02B2.82B2.95B1.73B
Total Debt3.42B3.43B3.43B3.44B3.45B3.44B
Total Liabilities158.95B110.96B102.97B147.30B169.38B98.31B
Stockholders Equity28.19B26.49B26.74B26.88B27.40B26.32B
Cash Flow
Free Cash Flow3.13B3.60B3.38B2.97B2.28B2.52B
Operating Cash Flow3.19B3.69B3.45B3.06B2.40B2.72B
Investing Cash Flow-59.30M-82.60M20.90M-489.80M58.40M-175.50M
Financing Cash Flow39.23B5.08B-48.34B-25.38B69.91B-2.46B

CME Group Technical Analysis

Technical Analysis Sentiment
Positive
Last Price271.42
Price Trends
50DMA
265.44
Positive
100DMA
269.95
Negative
200DMA
264.48
Positive
Market Momentum
MACD
-0.11
Positive
RSI
52.44
Neutral
STOCH
58.57
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CME, the sentiment is Positive. The current price of 271.42 is above the 20-day moving average (MA) of 267.36, above the 50-day MA of 265.44, and above the 200-day MA of 264.48, indicating a bullish trend. The MACD of -0.11 indicates Positive momentum. The RSI at 52.44 is Neutral, neither overbought nor oversold. The STOCH value of 58.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CME.

CME Group Risk Analysis

CME Group disclosed 28 risk factors in its most recent earnings report. CME Group reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

CME Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$96.59B25.9613.35%3.99%5.84%8.51%
75
Outperform
$26.19B26.8721.51%1.09%16.74%26.74%
73
Outperform
$48.85B30.5114.07%1.17%16.41%68.03%
71
Outperform
$83.80B26.7611.32%1.28%8.96%30.16%
68
Neutral
$24.79B35.8110.51%0.44%22.17%40.13%
68
Neutral
$82.87B27.6426.00%47.86%96.46%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CME
CME Group
268.00
55.44
26.08%
CBOE
Cboe Global Markets
252.64
55.22
27.97%
ICE
Intercontinental Exchange
147.52
-6.85
-4.44%
NDAQ
Nasdaq
85.56
8.33
10.79%
TW
Tradeweb Markets
106.88
-22.52
-17.40%
COIN
Coinbase Global
295.22
39.64
15.51%

CME Group Corporate Events

CME Group Earnings Call: Mixed Sentiments and Future Outlook
Oct 24, 2025

CME Group Inc’s recent earnings call painted a picture of mixed sentiments. On the one hand, the company celebrated strong performances in average daily volume, open interest, and market data revenue. On the other hand, concerns were raised due to a decline in overall revenue and energy volumes, coupled with regulatory challenges in prediction markets.

CME Group Reports Strong Q3 2025 Performance
Oct 23, 2025

CME Group Inc., a leading derivatives marketplace, facilitates trading across various asset classes, including futures, options, and cryptocurrencies, providing risk management and market opportunities for global participants.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 29, 2025